Organovo Holdings, Inc. is an American medical laboratory and research company which designs and develops functional, 3D human tissue for medical research and therapeutic applications.

According to the Complaint, Plaintiff asserts this action to remedy the alleged false and misleading disclosures made by Organovo and its Board of Directors in the Company’s proxy statement related to its 2019 annual meeting of stockholders.

This case was voluntarily dismissed on November 25, 2019.